1,016
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Assessment of the hepatorenal and hematological parameters of rats exposed to graded doses of lysine acetylsalicylate

, , , ORCID Icon & ORCID Icon
Pages 214-223 | Received 11 Jun 2020, Accepted 14 Dec 2021, Published online: 17 Feb 2022

References

  • Park K, Bavry AA. Aspirin: its risks, benefits, and optimal use in preventing cardiovascular events. Cleve Clin J Med. 2013;80(5):318–326. doi:10.3949/ccjm.80a.12146
  • Fuster V, Sweeny JM. Aspirin: a historical and contemporary therapeutic overview. Circulation. 2011;123(7):768–778. doi:10.1161/CIRCULATIONAHA.110.963843
  • El-Maddawy ZK, El-Ashmawy IM. Hepato-renal and hematological effects of diclofenac sodium in rats. Global J Pharmacol. 2013;7(2):123–132.
  • Kashef E, Sawy E, El-Ashmawy I, Massry E. Some pharmacological studies on nimesulide. Alex J Vet Sci 2013 Jan;38 (1):2014;38.
  • Guo C-G, Leung WK. Potential strategies in the prevention of nonsteroidal anti-inflammatory drugs-associated adverse effects in the lower gastrointestinal tract. Gut Liver. 2019.
  • Ahmed SA, Al-Lawati H, Jamali F. Dose-dependency of the cardiovascular risks of non-steroidal anti-inflammatory drugs. Inflammopharmacology. 2019;27(5):903–910. doi:10.1007/s10787-019-00621-5
  • Li J, Zhong L, Duan L, et al. Non-steroidal anti-inflam-matory drugs caused duodenal stenosis. J Biol Regul Homeost Agents. 2019;33(4):1183–1185.
  • Vyas A, Purohit A, Ram H. Assessment of dose-dependent reproductive toxicity of diclofenac sodium in male rats. Drug Chem Toxicol. 2019;42(5):478–486. doi:10.1080/01480545.2017.1421659.
  • Ibtisham F, Chen J, Niu Y, et al. Effect of aspirin on reproductive profile of male Rat An-overview. Int J Res Dev Pharm Life Sci. 2016;5:5–12.
  • El-Nakeeb A, El-Ashmawy I, El-Sawy A. Effect of meloxicam and tolfenamic acid on some reproductive aspects of male rats. Alexandria J Vet Sci. 2011;34(1):225–234.
  • Ferreira S. Prostaglandins, aspirin-like drugs and analgesia. Nat New Biol. 1972;240(102):200–203. doi:10.1038/newbio240200a0
  • Ferreira SH, Lorenzetti BB, Corrêa FM. Central and peripheral antialgesic action of aspirin-like drugs. Eur J Pharmacol. 1978;53(1):39–48. doi:10.1016/0014-2999(78)90265-0
  • Hall SL, Lorenc T. Secondary prevention of coronary artery disease. Am Fam Physician. 2010;81(3):289–296.
  • Würtz M. Aspirin in coronary artery disease: an appraisal of functions and limitations. Dan Med J. 2015;62(4):B5011-B.
  • Roubille C, Martel-Pelletier J, Davy J-M, et al. Cardiovascular adverse effects of anti-inflammatory drugs. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Inflammatory and Anti-Allergy Agents). 2013;12(1):55–67. doi:10.2174/1871523011312010008
  • Umezawa S, Higurashi T, Komiya Y, et al. Chemoprevention of colorectal cancer: past, present, and future. Cancer Sci. 2019;110(10):3018. doi:10.1111/cas.14149
  • Manzano A, Pérez-Segura P. Colorectal cancer chemoprevention: is this the future of colorectal cancer prevention? Scientific World J. 2012;2012. doi:10.1100/2012/327341
  • O'Brien CW, Juraschek SP, Wee CC. Prevalence of aspirin use for primary prevention of cardiovascular disease in the United States: results from the 2017 national health interview survey. Ann Intern Med. 2019.
  • Ma N, Liu X-W, Yang Y-J, et al. Preventive effect of aspirin eugenol ester on thrombosis in κ-carrageenan-induced rat tail thrombosis model. PLoS One. 2015;10(7).
  • Halvorsen S, Andreotti F, Jurriën M, et al. Aspirin therapy in primary cardiovascular disease prevention: a position paper of the European Society of Cardiology working group on thrombosis. J Am Coll Cardiol. 2014;64(3):319–327. doi:10.1016/j.jacc.2014.03.049
  • McNeil JJ, Nelson MR, Woods RL, et al. Effect of aspirin on all-cause mortality in the healthy elderly. N Engl J Med. 2018;379(16):1519–1528. doi:10.1056/NEJMoa1803955
  • McNeil JJ, Wolfe R, Woods RL, et al. Effect of aspirin on cardiovascular events and bleeding in the healthy elderly. N Engl J Med. 2018;379(16):1509–1518. doi:10.1056/NEJM-oa1805819
  • Vivas D, Martín A, Bernardo E, et al. Impact of intravenous lysine acetylsalicylate versus oral aspirin on prasugrel-inhibited platelets: results of a prospective, randomized, crossover study (the ECCLIPSE trial). Circ: Cardiovasc Interventions. 2015;8(5):e002281. doi:10.1161/CIRCIN-TERVENTIONS.114.002281
  • Needs CJ, Brooks PM. Clinical pharmacokinetics of the salicylates. Clin Pharmacokinet. 1985;10(2):164–177. doi:10.2165/00003088-198510020-00004
  • Ulrich CM, Bigler J, Potter JD. Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics. Nat Rev Cancer. 2006;6(2):130–140. doi:10.1038/nrc1801
  • Williams FM. Clinical significance of esterases in man. Clin Pharmacokinet. 1985;10(5):392–403. doi:10.2165/00003088-198510050-00002
  • Higgs GA, Salmon JA, Henderson B, et al. Pharmacokinetics of aspirin and salicylate in relation to inhibition of arachidonate cyclooxygenase and antiinflammatory activity. Proc Natl Acad Sci USA. 1987;84(5):1417–1420. doi:10.1073/pnas.84.5.1417
  • Libina V, Chaľka L, Kosheleva L, et al. Analgesic action and pharmacokinetics of lysine acetylsalicylate administered intramuscularly. Farmakol Toksikol. 1988;51(5):78–82.
  • Koch HJ, Raschka C. Anthropometric data and acetylsalicylic acid pharmacokinetics. Int J Clin Pharmacol Ther. 2002;40(1):30–34. Epub 2002/02/12. PubMed PMID: 11837380. doi:10.5414/cpp40030
  • Libina VV, Chaľka LA, Kosheleva LP, et al. [Analgesic action and pharmacokinetics of lysine acetylsalicylate administered intramuscularly]. Farmakol Toksikol. 1988; 51(5):78–82. Epub 1988/09/01. PubMed PMID: 3145214.
  • Svensson BA, Karlsten R, Kristensen JD, Sottile A, Bennett A, Gordh T, Jr. Intrathecal injection of lysine acetylsalicylic acid in the rat: a neurotoxicological study. Acta Anaesthesiol Scand. 1993;37(8):799–805. Epub 1993/11/01. PubMed PMID: 8279257. doi:10.1111/j.1399-6576.1993.tb03812.x
  • Baltazar MT, Dinis-Oliveira RJ, Guilhermino L, et al. New formulation of paraquat with lysine acetylsalicylate with low mammalian toxicity and effective herbicidal activity. Pest Manag Sci. 2013;69(4):553–558. Epub 2012/10/31. PubMed PMID: 23109273. doi:10.1002/ps.3412
  • Silva VS, Gonçalves PP. Effect of lysine acetylsalicylate on aluminium accumulation and (Na(+)/K(+))ATPase activity in rat brain cortex synaptosomes after aluminium ingestion. Toxicol Lett. 2015;232(1):167–174. Epub 2014/12/03. PubMed PMID: 25455452. doi:10.1016/j.toxlet.2014.10.014
  • Marissal J-P, Selke B, Lebrun T. Economic assessment of the secondary prevention of ischaemic events with lysine acetylsalicylate. Pharmacoeconomics. 2000;18(2):185–200. doi:10.2165/00019053-200018020-00008
  • Bretagne J, Feuillu A, Gosselin M, et al. Aspirin and gastroduodenal toxicity. A double-blind endoscopic study of the effects of placebo, aspirin and lysine acetylsalicylate in healthy subjects. Gastroenterol Clin Biol. 1984;8(1):28–32.
  • Brighton TA, Eikelboom JW, Mann K, et al. Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med. 2012;367:1979–1987. doi:10.1056/NEJMoa1210384
  • Gurfinkel EP, Altman R, Scazziota A, et al. Fast platelet suppression by lysine acetylsalicylate in chronic stable coronary patients. Potential clinical impact over regular aspirin for coronary syndromes. Clin Cardiol. 2000;23(9):697–700. doi:10.1002/clc.4960230912
  • Majluf-Cruz A, Chavez-Ochoa A, Majluf-Cruz K, et al. Effect of combined administration of clopidogrel and lysine acetylsalicylate versus clopidogrel and aspirin on platelet aggregation and activated GPIIb/IIIa expression in healthy volunteers. Platelets. 2006;17(2):105–107. doi:10.1080/09537100500438156
  • Paget GE, Barnes JM. CHAPTER 6 - toxicity tests. In: Laurence DR, Bacharach AL, editors. Evaluation of drug activities. Academic Press; 1964. p. 135–166.
  • Huang WD, Wang JZ, Lu YQ, et al. Lysine acetylsalicylate ameliorates lung injury in rats acutely exposed to paraquat. Chin Med J (Engl). 2011;124(16):2496–2501. Epub 2011/09/22. PubMed PMID: 21933594.
  • Benjamin M. Outline cf veterinary clinical pathology. 3rd Edition. 3rd ed. Ames, USA: Iowa State University Press; 1978.
  • Dacie J, Lewis S. Practical haematology. 6th ed London: Churchill Livingstone; 1984.
  • Lubran MM. The measurement of total serum proteins by the Biuret method. Ann Clin Lab Sci. 1978;8(2):106–110. Epub 1978/03/01. PubMed PMID: 345944.
  • Doumas BT, Biggs HG, Arends RL, et al. Determination of serum albumin. In: Cooper GR, editor. Standard methods of clinical chemistry. 7. New York: Academic press; 1972. p. 175–188.
  • Coles E. Veterinary clinical pathology. EH Coles. 2nd ed. Philadelphia, USA: WB Saunders Company; 1974.
  • Harries M. Carletons histopathological technique.Toronto (NY): Oxford Univ Press; 1989.
  • SAS G, STAT User’s. Statistics, Version. Statistical Analysis System Institute, Cary, NC; 2001.
  • Salvagno GL, Sanchis-Gomar F, Picanza A, et al. Red blood cell distribution width: A simple parameter with multiple clinical applications. Crit Rev Clin Lab Sci. 2015;52(2):86–105. doi:10.3109/10408363.2014.992064
  • Da Costa L, Suner L, Galimand J, et al. Diagnostic tool for red blood cell membrane disorders: Assessment of a new generation ektacytometer. Blood Cells, Mol Dis. 2016;56(1):9–22. doi:10.1016/j.bcmd.2015.09.001
  • Agrawal R, Sherwood J, Chhablani J, et al. Red blood cells in retinal vascular disorders. Blood Cells, Mol Dis. 2016;56(1):53–61. doi:10.1016/j.bcmd.2015.10.003
  • Al-Taei BS. Effect of aspirin on sperm specification and some hematological parameters in male albino white rat. J Biotechnol Res Center. 2014;8(4):34–38. doi:10.24126/jobrc.2014.8.4.377
  • Adewusi E, Afolayan A. Safety evaluation of the extract from the roots of pelargonium reniforme Curtis in male wistar rats. African J Pharm Pharmacol. 2009;3(8):368–373.
  • Oyedeji K, Bolarinwa A, Adeyemo C. Effect of aspirin on haematological and plasma biochemical parameters in male Albino rats. J Dent Med Sci. 2013;3(5):80–83.
  • Vyas A, Ram H, Purohit A, et al. Adverse effects of subchronic dose of aspirin on reproductive profile of male rats. J Pharm (Cairo). 2016;2016.
  • Miescher P. Blood dyscrasias secondary to non-steroidal anti-inflammatory drugs. Med Toxicol. 1986;1:57–70.
  • Rainsford KD. Side effects and toxicology of the salicylates. In: Rainsford KD, editor. Aspirin and related drugs. London: Taylor & Francis; 2004. p. 367–554.
  • Navratil L, Blehova Z, Drbohlavova H. Effect of continuous, long-term administrations of acetylsalicylic acid on hematological and hemocoagulation changes in the rat. Boll Chim Farm. 1992;131(10):363–368.
  • Rainsford KD. Aspirin and the salicylates. London; Boston: Butterworths; 1984.
  • Sarkar A, Chakraborti A, Saha U, et al. Effects of aspirin and paracetamol on ATPases of human fetal brain: an in vitro study. Indian J Exp Biol. 1989;27(9):802–804.
  • Tomoda T, Takeda K, Kurashige T, et al. Acetylsalicylate (ASA)-induced mitochondrial dysfunction and its potentiation by Ca2 + . Liver. 1994;14(2):103–108. doi:10.1111/j.1600-0676.1994.tb00056.x
  • Modi D, Merchant M. In vitro effects of aspirin and salicylate on erythrocytes: size and Na+/K+ ATPase activity. Indian J Pharmacol. 2003;35:27–31.
  • Dacie J, Lewis S. Practical haematology. 7th ed New York: Churchill Livingstone; 1991.
  • Tian Z, Liu H, Su X, et al. Role of elevated liver transaminase levels in the diagnosis of liver injury after blunt abdominal trauma. Exp Ther Med. 2012;4(2):255–260. doi:10.3892/etm.2012.575
  • Purohit A, Daradka H. Effect of mild hyperlipidaemia on testicular cell population dynamics in albino rats. Indian J Exp Biol. 1999;37(4):396–398.
  • Aprioku JS, Nwidu LL, Amadi CN. Evaluation of toxicological profile of ibuprofen in Wistar albino rats. Am J Bio Med Sci. 2014;6:32–40. doi:10.5099/aj140100032
  • Prescott L. Hepatotoxicity of mild analgesics. Br J Clin Pharmacol. 1980;10(S2):373S–379S. doi:10.1111/j.1365-2125.1980.tb01825.x
  • Ebong P, Eyong E, Udosen E. Effects of aspirin (acetylsalicylic acid) and Cataflam (potassium diclofenac) on some biochemical parameters in rats. Afr J Med Med Sci. 1998;27(3-4):243–246.
  • Ingram LR. Liver function. In: Anderson SC, Cockayne S, editor. Clinical chemistry concepts and applications. Philadelphia: Saunders; 1993. p. 280–317.
  • Doxey DL. Veterinary Clinical pathology. 1st ed. London: Baillière Tindall; 1971.
  • Tiefenbach B, Wichner S. Dose dependence and mechanism of the acute effect of methamidophos on the immune system of the mouse. Z Gesamte Hyg. 1985;31(4):228–231.
  • Bush B. Interpretation of laboratory results for small animal clinicians. Blackwell Scientific Publications Ltd; 1991.
  • Ejaz P, Bhojani K, Joshi V. NSAIDs and kidney. J Assoc Physicians India. 2004;52:632–640.
  • Gaspari F, Perico N, Matalone M, et al. Precision of plasma clearance of iohexol for estimation of GFR in patients with renal disease. J Am Soc Nephrol. 1998;9(2):310–313. doi:10.1681/ASN.V92310
  • Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem. 1992;38(10):1933–1953. doi:10.1093/clin-chem/38.10.1933
  • Karima R, Matsumoto S, Higashi H, et al. The molecular pathogenesis of endotoxic shock and organ failure. Mol Med Today. 1999;5(3):123–132. doi:10.1016/S1357-4310(98)01430-0
  • Méndez-Sánchez N, Chavez-Tapia N, Uribe M. New molecular features of cholestatic diseases of the liver. Rev Invest Clin. 2003;55(5):546–556.